Marie A. Chisholm-Burns

Marie A. Chisholm-Burns

Auto-generated profile, based on publicly available information

Marie A. Chisholm-Burns

Oregon Health & Science University , Portland, OR 97239

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
PDF file
MCMarie A. Chisholm-Burns
Marie A. Chisholm-Burns
CSChristina A. Spivey
Christina A. Spivey

19 March 2019 in American Journal of Health-System Pharmacy
Verified
Journal Article
Closed access
PDF file
MCMarie A Chisholm-Burns
Marie A Chisholm-Burns
CSChristina A Spivey
Christina A Spivey
ESErin Sherwin
Erin Sherwin
JWJames Wheeler
James Wheeler
KHKenneth Hohmeier
Kenneth Hohmeier
The purpose of this review is to (1) provide information concerning the opioid crisis including origins, trends, and some important related laws/policies; and (2) summarize the current involvement and impact of pharmacists in helping to address the crisis, as well as examine practices in other healthcare disciplines from which pharmacists might derive guidance and strategies. Contributors to the opioid crisis included campaigns to treat pain as a fifth vital sign and to use opioids in treatment of non-cancer-related pain, as well as aggressive marketing of opioid analgesics by pharmaceutical companies. To address the crisis, numerous strategies have been implemented at the policy/legislative, health-system, and patient levels, such as prescription drug monitoring programs (PDMPs), increased regulation of pain clinics, and expanded use of naloxone. Pharmacists have a critical role to play in interventions to address opioid misuse and reduce harm resulting from misuse. Such interventions include patient screening and risk stratification, patient and community education and outreach concerning appropriate pain management, medication reviews/medication therapy management, education on safe storage and disposal, distribution of naloxone/opioid rescue kits and training on their proper use, and referral of patients to addiction treatment, among other strategies. Pharmacists have multiple, complex roles in addressing the opioid crisis. Outcomes of several studies provide substantial evidence that pharmacists can make an impact through appropriate pain management, use of PDMPs, opioid overdose prevention training, and medication reviews and counseling, among other interventions.

1 March 2017 in American Journal of Health-System Pharmacy
Verified
Journal Article
Closed access
PDF file
MCMarie A. Chisholm-Burns
Marie A. Chisholm-Burns
CSChristina A. Spivey
Christina A. Spivey
THTracy Hagemann
Tracy Hagemann
MJMichelle A. Josephson
Michelle A. Josephson
Geraldine Ferraro, a U.S. congresswoman and the first woman to run for U.S. vice president on a major party ticket, once stated that “some leaders are born women.”[1][1] There is little doubt that statement is true. However, former U.S. Senator and Secretary of State Hillary Clinton’s failed

1 September 2013 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
MCM. A. Chisholm‐Burns
M. A. Chisholm‐Burns
CSC. A. Spivey
C. A. Spivey
JZJ. Graff Zivin
J. Graff Zivin
JLJ. K. Lee
J. K. Lee
ESE. Sredzinski
E. Sredzinski
ETE. A. Tolley
E. A. Tolley
The objective of this randomized controlled trial was to assess the effects of a 1-year behavioral contract intervention on immunosuppressant therapy (IST) adherence and healthcare utilizations and costs among adult renal transplant recipients (RTRs). The sample included adult RTRs who were at least 1 year posttransplant, taking tacrolimus or cyclosporine and served by a specialty pharmacy. Pharmacy refill records were used to measure adherence and monthly questionnaires were used to measure healthcare utilizations. Direct medical costs were estimated using the 2009 Medicare Expenditure Panel Survey. Adherence was analyzed using the GLM procedure and the MIXED procedure of SAS. Rate ratios and 95% confidence intervals were estimated to quantify the rate of utilizing healthcare services relative to treatment assignment. One hundred fifty RTRs were enrolled in the study. Intervention group RTRs (n = 76) had higher adherence than control group RTRs (n = 74) over the study period (p < 0.01). And 76.1% of the intervention group compared with 42.7% of the control group was not hospitalized during the 1-year study period (RR = 1.785; 95% CI: 1.314, 2.425), resulting in cost savings. Thus, evidence supports using behavioral contracts as an effective adherence intervention that may improve healthcare outcomes and lower costs.

1 December 2013 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
FWFrancis L Weng
Francis L Weng
SCSheenu Chandwani
Sheenu Chandwani
KKKaren M Kurtyka
Karen M Kurtyka
CZChristopher Zacker
Christopher Zacker
MCMarie A Chisholm-Burns
Marie A Chisholm-Burns
KDKitaw Demissie
Kitaw Demissie
Among kidney transplant recipients, non-adherence with immunosuppressive medications frequently precedes allograft loss. We sought to determine the prevalence and correlates of medication non-adherence among kidney transplant recipients.

11 December 2013 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
CSChristina A. Spivey
Christina A. Spivey
MCMarie A. Chisholm‐Burns
Marie A. Chisholm‐Burns
BDBita Damadzadeh
Bita Damadzadeh
DBDean Billheimer
Dean Billheimer